Trending Stock News

Krensavage Asset Management Has Lowered Its Enanta Pharmaceuticals (ENTA) Position as Market Value Rose; As Jpmorgan Chase & Co (JPM) Share Price Declined, Holder Quaker Capital Investments Trimmed Its Stake by $1.33 Million

Krensavage Asset Management Llc decreased its stake in Enanta Pharmaceuticals Inc (ENTA) by 8.25% based on its latest 2017Q3 regulatory filing with the SEC. Krensavage Asset Management Llc sold 91,145 shares as the company’s stock rose 11.35% with the market. The institutional investor held 1.01M shares of the health care company at the end of 2017Q3, valued at $47.45 million, down from 1.10 million at the end of the previous reported quarter. Krensavage Asset Management Llc who had been investing in Enanta Pharmaceuticals Inc for a number of months, seems to be less bullish one the $1.56B market cap company. The stock increased 0.30% or $0.24 during the last trading session, reaching $81.58. About 142,645 shares traded. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has risen 40.91% since February 19, 2017 and is uptrending. It has outperformed by 24.21% the S&P500.

Quaker Capital Investments Llc decreased its stake in Jpmorgan Chase & Co (JPM) by 35.3% based on its latest 2017Q3 regulatory filing with the SEC. Quaker Capital Investments Llc sold 13,985 shares as the company’s stock declined 6.04% while stock markets rallied. The institutional investor held 25,631 shares of the major banks company at the end of 2017Q3, valued at $2.45M, down from 39,616 at the end of the previous reported quarter. Quaker Capital Investments Llc who had been investing in Jpmorgan Chase & Co for a number of months, seems to be less bullish one the $392.76 billion market cap company. The stock decreased 0.72% or $0.83 during the last trading session, reaching $114.68. About 13.21 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since February 19, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Among 33 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 13 Hold. Therefore 55% are positive. JPMorgan Chase & Co had 110 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of JPMorgan Chase & Co. (NYSE:JPM) earned “Buy” rating by Jefferies on Tuesday, June 6. The stock of JPMorgan Chase & Co. (NYSE:JPM) has “Hold” rating given on Friday, July 14 by Oppenheimer. Atlantic Securities upgraded the shares of JPM in report on Monday, January 18 to “Overweight” rating. The firm has “Buy” rating by Jefferies given on Tuesday, July 21. The rating was maintained by Robert W. Baird on Tuesday, January 2 with “Hold”. Vetr upgraded JPMorgan Chase & Co. (NYSE:JPM) rating on Tuesday, September 1. Vetr has “Buy” rating and $71.88 target. Berenberg initiated it with “Sell” rating and $52 target in Wednesday, July 13 report. The stock of JPMorgan Chase & Co. (NYSE:JPM) has “Outperform” rating given on Monday, August 17 by KBW. Keefe Bruyette & Woods upgraded JPMorgan Chase & Co. (NYSE:JPM) on Tuesday, February 13 to “Buy” rating. The firm earned “Buy” rating on Wednesday, January 24 by Credit Suisse.

Since August 21, 2017, it had 1 buying transaction, and 9 insider sales for $22.34 million activity. The insider Scher Peter sold 26,532 shares worth $3.01M. $1.84 million worth of JPMorgan Chase & Co. (NYSE:JPM) shares were sold by BACON ASHLEY. 9,194 shares were sold by Lake Marianne, worth $1.03M. The insider CROWN JAMES S bought $825,327. On Saturday, January 13 the insider Giles Nicole sold $425,399. $5.43M worth of JPMorgan Chase & Co. (NYSE:JPM) shares were sold by Petno Douglas B.

Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.28, from 1.19 in 2017Q2. It fall, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. 1St Source Fincl Bank owns 107,854 shares. Brookmont Cap has 3.52% invested in JPMorgan Chase & Co. (NYSE:JPM) for 67,261 shares. Kcm Investment Ltd Liability Corporation accumulated 130,512 shares. Texas-based Smith Asset Management Group Inc LP has invested 0.84% in JPMorgan Chase & Co. (NYSE:JPM). Agf Invests holds 2.26% or 2.17 million shares. 19,017 are held by Balasa Dinverno And Foltz Ltd Liability Company. Hartline Invest accumulated 14,939 shares. Stevens Mgmt LP owns 0.9% invested in JPMorgan Chase & Co. (NYSE:JPM) for 251,895 shares. Sarasin & Ltd Liability Partnership accumulated 2.40M shares or 4.61% of the stock. First Bank & Trust Sioux Falls accumulated 8,135 shares. Oak Ridge Invs Lc reported 0.03% stake. Jupiter Asset Ltd owns 2.16% invested in JPMorgan Chase & Co. (NYSE:JPM) for 662,652 shares. Contravisory Mngmt has invested 0.02% in JPMorgan Chase & Co. (NYSE:JPM). Signaturefd Ltd Com owns 16,546 shares for 0.21% of their portfolio. Moreover, Boston Rech And Mgmt has 0.44% invested in JPMorgan Chase & Co. (NYSE:JPM).

Krensavage Asset Management Llc, which manages about $60.40 million and $320.80 million US Long portfolio, upped its stake in United Therapeutics Corp (NASDAQ:UTHR) by 73,515 shares to 346,511 shares, valued at $40.61 million in 2017Q3, according to the filing.

Leave a Reply

Your email address will not be published. Required fields are marked *